Stephen A. Munk

888 total citations
15 papers, 780 citations indexed

About

Stephen A. Munk is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Stephen A. Munk has authored 15 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 2 papers in Pharmaceutical Science. Recurrent topics in Stephen A. Munk's work include DNA and Nucleic Acid Chemistry (4 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Stephen A. Munk is often cited by papers focused on DNA and Nucleic Acid Chemistry (4 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Stephen A. Munk collaborates with scholars based in United States. Stephen A. Munk's co-authors include Dale L. Boger, Takayoshi Ishizaki, Hamideh Zarrinmayeh, Paul A. Kitos, Oranart Suntornwat, Ronald J. Wysocki, Minou Bina, Subas M. Sakya, Michael E. Garst and Robert S. Coleman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Stephen A. Munk

15 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen A. Munk United States 12 530 489 105 80 71 15 780
Zainab M. Elsayed Egypt 16 488 0.9× 386 0.8× 39 0.4× 84 1.1× 18 0.3× 33 645
David E. Kaelin United States 10 383 0.7× 192 0.4× 48 0.5× 122 1.5× 10 0.1× 14 483
Jérémie Fournier Dit Chabert France 9 588 1.1× 187 0.4× 38 0.4× 88 1.1× 22 0.3× 10 677
Swagatika Das Canada 13 257 0.5× 177 0.4× 48 0.5× 25 0.3× 17 0.2× 19 386
Hideo Terauchi Japan 11 547 1.0× 153 0.3× 90 0.9× 72 0.9× 6 0.1× 14 648
Darshan Makhey United States 7 119 0.2× 309 0.6× 71 0.7× 151 1.9× 54 0.8× 8 432
T. MIYAMOTO Japan 11 279 0.5× 174 0.4× 29 0.3× 74 0.9× 6 0.1× 21 390
Michael Reuman United States 12 608 1.1× 228 0.5× 40 0.4× 75 0.9× 7 0.1× 27 778
Eugene B. Grant United States 11 414 0.8× 172 0.4× 31 0.3× 35 0.4× 11 0.2× 17 599
Katja Hübel Germany 12 486 0.9× 255 0.5× 25 0.2× 73 0.9× 16 0.2× 13 696

Countries citing papers authored by Stephen A. Munk

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Munk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Munk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Munk more than expected).

Fields of papers citing papers by Stephen A. Munk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Munk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Munk. The network helps show where Stephen A. Munk may publish in the future.

Co-authorship network of co-authors of Stephen A. Munk

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Munk. A scholar is included among the top collaborators of Stephen A. Munk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Munk. Stephen A. Munk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Moos, Walter H., Susan C. Miller, & Stephen A. Munk. (2016). Managing the Drug Discovery Process: How to Make It More Efficient and Cost-Effective. 2 indexed citations
2.
Thompson, Charles D., et al.. (1997). Mechanisms of Adrenergic Agonist Induced Allergy Bioactivation and Antigen Formation. Experimental Eye Research. 64(5). 767–773. 18 indexed citations
3.
Munk, Stephen A., James A. Burke, E. Padillo, et al.. (1997). Synthesis and Evaluation of 2-(Arylamino)imidazoles as α2-Adrenergic Agonists. Journal of Medicinal Chemistry. 40(1). 18–23. 40 indexed citations
4.
Thompson, Charles D., Stanley P. Kolis, Pamela H. Gulden, et al.. (1997). A Proposed Mechanism for p-Aminoclonidine Allergenicity Based on Its Relative Oxidative Lability. Chemical Research in Toxicology. 10(9). 1032–1036. 7 indexed citations
5.
Munk, Stephen A., Ronald Lai, J. Burke, et al.. (1996). Synthesis and Pharmacologic Evaluation of 2-endo-Amino-3-exo- isopropylbicyclo[2.2.1]heptane:  A Potent Imidazoline1 Receptor Specific Agent. Journal of Medicinal Chemistry. 39(6). 1193–1195. 41 indexed citations
6.
Munk, Stephen A., Charles Gluchowski, James A. Burke, et al.. (1996). Synthesis and Evaluation of 2-[(5-Methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a Potent, Peripherally Acting α2Adrenoceptor Agonist. Journal of Medicinal Chemistry. 39(18). 3533–3538. 10 indexed citations
7.
Sullivan, Robert W., Vincent M. Coghlan, Stephen A. Munk, Harold W. Moore, & Michael W. Reed. (1994). DNA Cleavage by 4-Alkynyl-3-methoxy-4-hydroxycyclobutenones. The Journal of Organic Chemistry. 59(9). 2276–2278. 35 indexed citations
8.
Boger, Dale L. & Stephen A. Munk. (1992). DNA alkylation properties of enhanced functional analogs of CC-1065 incorporating the 1,2,9,9a-tetrahydrocyclopropa[1,2-c]benz[1,2-e]indol-4-one (CBI) alkylation subunit. Journal of the American Chemical Society. 114(14). 5487–5496. 55 indexed citations
9.
Boger, Dale L., Stephen A. Munk, & Takayoshi Ishizaki. (1991). (+)-CC-1065 DNA alkylation: observation of an unexpected relationship between cyclopropane electrophile reactivity and the intensity of DNA alkylation. Journal of the American Chemical Society. 113(7). 2779–2780. 49 indexed citations
10.
11.
Boger, Dale L., Takayoshi Ishizaki, Subas M. Sakya, et al.. (1991). Synthesis and preliminary evaluation of (+)-CBI-indole2: an enhanced functional analog of (+)-CC-1065. Bioorganic & Medicinal Chemistry Letters. 1(2). 115–120. 34 indexed citations
12.
Boger, Dale L., Stephen A. Munk, & Hamideh Zarrinmayeh. (1991). (+)-CC-1065 DNA alkylation: key studies demonstrating a noncovalent binding selectivity contribution to the alkylation selectivity. Journal of the American Chemical Society. 113(10). 3980–3983. 52 indexed citations
13.
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zainab M. Elsayed Breakdown of academic impact, for papers by David E. Kaelin Breakdown of academic impact, for papers by Jérémie Fournier Dit Chabert Breakdown of academic impact, for papers by Swagatika Das Breakdown of academic impact, for papers by Hideo Terauchi Breakdown of academic impact, for papers by Darshan Makhey Breakdown of academic impact, for papers by T. MIYAMOTO Breakdown of academic impact, for papers by Michael Reuman Breakdown of academic impact, for papers by Eugene B. Grant Breakdown of academic impact, for papers by Katja Hübel
Rankless by CCL
2026